Relatively small birth size and accelerated early growth of Japanese type 1 diabetic children with younger onset

Yumiko Kotani1, Ichiro Yokota1, Shoji Kagami1

  • 1Department of Pediatrics, Tokushima University Graduate School of Medical Sciences, Tokushima, Japan.

Insights

Japanese children with type 1 diabetes show smaller birth size, especially those diagnosed younger. Accelerated growth after birth may precede earlier onset of type 1 diabetes (T1DM).

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 1 diabetes (T1DM) is a significant pediatric endocrine disorder.
  • Understanding anthropometric changes preceding T1DM onset is crucial for early detection and prevention strategies.

Purpose of the Study:

  • To investigate anthropometric parameter changes from birth to T1DM onset in Japanese children.
  • To identify potential growth patterns associated with different age groups at T1DM diagnosis.

Main Methods:

  • Retrospective analysis of 199 Japanese children diagnosed with T1DM between 0-16 years (1990-2003).
  • Subjects categorized into three groups based on age at onset: 0-5, 5-10, and 10-16 years.
  • Comparison of height and weight standard deviation scores (SDS) from birth to diabetes onset.

Main Results:

  • Children with earlier T1DM onset (<5 years) exhibited significantly lower height and weight SDS at birth compared to older onset groups.
  • The younger onset group showed a significant increase in height SDS from birth to T1DM onset.
  • No significant height SDS changes were observed from birth to onset in the older age groups.

Conclusions:

  • Smaller birth size and accelerated postnatal growth may characterize Japanese children with early-onset T1DM.
  • These findings support the hypothesis linking accelerated growth and subsequent insulin resistance to earlier T1DM development.

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17